Zosano Pharma OverviewZosano Pharma EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ZSAN.
Quarterly EBIT
-$33.34M
↓ 314.37% YoY
As of Mar 31, 2022
Annual EBIT (TTM)
-$55.03M
↓ 70.83% YoY
Trailing 12 months ending Mar 31, 2022
Zosano Pharma OverviewEBIT (Earnings Before Interest and Taxes) analysis for ZSAN.
As of Mar 31, 2022
Trailing 12 months ending Mar 31, 2022